TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biopharmacon, AB
Closing information (x1000 EUR)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
32
|
23
|
41 |
| Financial expenses |
0
|
6
|
3 |
| Earnings before taxes |
2
|
192
|
11 |
| EBITDA |
-3
|
1
|
10 |
| Total assets |
577
|
636
|
477 |
| Current assets |
542
|
596
|
430 |
| Current liabilities |
7
|
6
|
11 |
| Equity capital |
564
|
621
|
454 |
| - share capital |
8
|
9
|
10 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
97.7%
|
97.6%
|
95.2% |
| Turnover per employee |
32
|
23
|
41 |
| Profit as a percentage of turnover |
6.2%
|
834.8%
|
26.8% |
| Return on assets (ROA) |
0.3%
|
31.1%
|
2.9% |
| Current ratio |
7742.9%
|
9933.3%
|
3909.1% |
| Return on equity (ROE) |
0.4%
|
30.9%
|
2.4% |
| Change turnover |
12
|
-16
|
-31 |
| Change turnover % |
57%
|
-41%
|
-43% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.